INS and cystic fibrosis: Rigorous clinical trials are warranted to determine if modifying the macronutrient quality of the CF diet will influence glycemic outcomes, such as insulin secretion or insulin sensitivity, and ultimately mitigate decline in glucose tolerance among individuals with CF.